Orchid Pharma Ltd (BOM:524372)
₹ 1147.85 29.6 (2.65%) Market Cap: 58.22 Bil Enterprise Value: 56.86 Bil PE Ratio: 60.19 PB Ratio: 4.98 GF Score: 79/100

Q4 2024 Orchid Pharma Ltd Earnings Call Transcript

May 24, 2024 / 10:30AM GMT
Release Date Price: ₹1026.55 (-6.42%)
Operator

Ladies and gentlemen, good day, and welcome to Orchid Pharma Limited Q4 FY '24 Earnings Conference Call hosted by Systematix Institutional Equity. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Vishal Manchanda from Systematix Institutional Equities. Thank you, and over to you, sir.

Vishal Manchanda;India;Ltd.
Systematix Shares & Stocks;Research Division - SVP of Institutional Research

() -

Thank you, Manav. Good evening, everyone. On behalf of Systematix Institutional Equities, I welcome you to the Q4 and full year FY '24 earnings call of Orchid Pharma. We thank the Orchid Pharma management for giving us an opportunity to host the call. Today, we have with us the senior management of Orchid Pharma, be presented by Mr. Manish Dhanuka, Managing Director; Mr. Mirdul Dhanuka, Full-time Director; and Mr. Sunil Kumar Gupta, Chief Financial Officer.

I'll now hand over the call to the company management for opening remarks. Over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot